Profile picture

Doctor Dina Labib

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients
Presentation
CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients
Read more
Prevalence and predictors of right ventricular dysfunction in cancer patients treated with cardiotoxic chemotherapy - A prospective cardiovascular magnetic resonance study
Presentation
Prevalence and predictors of right ventricular dysfunction in cancer patients treated with cardiotoxic chemotherapy - A prospective cardiovascular magnetic resonance study
Read more
Value of baseline clinical and CMR characteristics for the prediction of cancer therapeutics-related cardiac dysfunction: results from the Cardiotoxicity Prevention Research Initiative (CAPRI)
Presentation
Value of baseline clinical and CMR characteristics for the prediction of cancer therapeutics-related cardiac dysfunction: results from the Cardiotoxicity Prevention Research Initiative (CAPRI)
Read more

ESC 365 is supported by

novartis Explore sponsored resources